Found: 18
Select item for more details and to access through your institution.
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2013, v. 33, n. 6, p. 414
- By:
- Publication type:
- Article
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 5, p. 787, doi. 10.1093/cid/cix419
- By:
- Publication type:
- Article
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico.
- Published in:
- Pan American Journal of Public Health, 2013, v. 33, n. 6, p. 414
- By:
- Publication type:
- Article
Protective effect of a synthetic peptide comprising the complete pres2 region of the hepatitis b virus surface protein.
- Published in:
- Journal of Medical Virology, 1989, v. 28, n. 1, p. 7, doi. 10.1002/jmv.1890280103
- By:
- Publication type:
- Article
Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challenge.
- Published in:
- Journal of Medical Virology, 1989, v. 27, n. 2, p. 120, doi. 10.1002/jmv.1890270210
- By:
- Publication type:
- Article
Establishment and characterization of a chronic infectious mononucleosislike syndrome in common marmosets.
- Published in:
- Journal of Medical Virology, 1986, v. 18, n. 4, p. 369, doi. 10.1002/jmv.1890180410
- By:
- Publication type:
- Article
Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides.
- Published in:
- Nature, 1983, v. 304, n. 5928, p. 699, doi. 10.1038/304699a0
- By:
- Publication type:
- Article
Primary structure, gene organization and polypeptide expression of poliovirus RNA.
- Published in:
- Nature, 1981, v. 291, n. 5816, p. 547, doi. 10.1038/291547a0
- By:
- Publication type:
- Article
Human capital gaps in vaccine development: an issue for global vaccine development and global health.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1395, n. 1, p. 3, doi. 10.1111/nyas.13316
- By:
- Publication type:
- Article
Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM<sub>197</sub> conjugate vaccine.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1263, n. 1, p. 15, doi. 10.1111/j.1749-6632.2012.06673.x
- By:
- Publication type:
- Article
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.
- Published in:
- 1998
- By:
- Publication type:
- journal article
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 8, p. 1427, doi. 10.1002/pbc.25502
- By:
- Publication type:
- Article
22<sup>nd</sup> Annual Symposium on Nonhuman Primate Models for AIDS November 3 – 6, 2004 San Antonio, TX.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Residual HIV Type 1 RNA and DNA in Lymph Nodes and HIV RNA in Genital Secretions and in Cerebrospinal Fluid after Suppression of Viremia for 2 Years.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 9, p. 1318
- By:
- Publication type:
- Article
CORRESPONDENCE.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 6, p. 992
- By:
- Publication type:
- Article
Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease...
- Published in:
- Journal of Infectious Diseases, 2000, v. 182, n. 3, p. 758, doi. 10.1086/315782
- By:
- Publication type:
- Article
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIVInfected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 1, p. 18, doi. 10.1093/infdis/jiu631
- By:
- Publication type:
- Article